微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
郁闷的鞋套-2021-07-20 12:42
$Nevro(NVRO)$ 2021年7月19日,Nevro公司宣布,其专有的10 kHZ脊髓刺激(SCS)“Senza”系统,已获得美国FDA批准,用于治疗疼痛性糖尿病神经病变(PDN)引起的慢性疼痛。新闻稿指出,这是FDA批准的首款以PDN为适应症的脊髓刺激系统。该公司将根据本次批准,推出的名为“HFX”的PDN治疗相关产品。HF...查看全文
智通财经APP获悉,鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购,摩根大通分析师Robbie Marcus列出了潜在的收购目标,包括:英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro Corp.(NVRO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001564590-18-018945 Size: 8 MB 网页链接
$Nevro Corp.(NVRO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-02 AccNo: 0001564590-18-018945 Size: 8 MB 网页链接
$Nevro Corp.(NVRO)$ 8-K - Current report Filed: 2018-08-02 AccNo: 0001564590-18-018905 Size: 313 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Nevro Corp.(NVRO)$ 8-K - Current report Filed: 2018-07-30 AccNo: 0001193125-18-231584 Size: 31 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nevro Corp.(NVRO)$ 内部交易: 2018-07-25,VP, Quality,Alleavitch Doug ,期权,1500普通股, $53.70
$Nevro Corp.(NVRO)$ 8-K - Current report Filed: 2018-07-25 AccNo: 0001193125-18-225166 Size: 26 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nevro Corp.(NVRO)$ 8-K - Current report Filed: 2018-07-25 AccNo: 0001193125-18-225166 Size: 26 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nevro Corp.(NVRO)$ 美东时间 2018-08-02 盘后 披露财报,预期EPS -0.3 网页链接
$Nevro Corp.(NVRO)$ 内部交易: 2018-07-18,CFO,Galligan Andrew H ,期权,7400普通股, $1.44
$Nevro Corp.(NVRO)$ 8-K - Current report Filed: 2018-07-16 AccNo: 0001564590-18-016856 Size: 57 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接